Back to speakers


Professor of Gastroenterology


City: Milan

Institution: Humanitas Hospital Rozzano Milan


Biography of Massimo COLOMBO

Professor Massimo Colombo is Director of the Center for Translational Research in Liver Disease at Humanitas Research Hospital ,Rozzano Italy.In the past 15 years he has been Chairman of the Division of Gastroenterology and Hepatology and Chairman of the Department of Medicine and Liver, Kidney, Lung, Bone Marrow and Organ Transplantation at IRCCS Maggiore Hospital in Milan, Italy. He has also been a Professor of Medicine and Gastroenterology at the University of Milan for more than 25 years. Professor Colombo gained his medical degree from the University of Milan, before completing a residency in gastroenterology at IRCCS Maggiore Hospital. Subsequently he undertook an international fellowship in liver diseases at Mount Sinai Hospital in New York, USA(1974-1975), before returning to IRCCS Maggiore Hospital.

Professor Colombo’s research interests include the diagnosis and treatment of viral hepatitis and liver cancer. A member of many professional societies including EASL, AASLD and several Italian societies, he is the recipient of numerous awards including the 2010 European Association Study Liver (EASL) Recognition Award for outstanding medical and scientific contributions, the Italian Association for the Study of the Liver (AISF) Distinguished Service Award, the Thanhauser Medal Award of the German Society of Gastroenterology and the Nelson Fausto Award of the International Liver Cancer Association(ILCA). Professor Colombo was Editor-in-Chief of the Journal of Hepatology from 2005–2009 and currently sits of the editorial boards of many hepatology journals. In September 2016 he was appointed Chairman of EASL International Liver Foundation. He has authored more than 500 original manuscripts in peer-reviewed journals, with an H-index of 83 and more than 27,000 citations.

PHC's participations

13th PHC – 2020

Monday, January 13th 2020

New EASL Recommendations for the management of occupational liver disease -

Tuesday, January 14th 2020


12th PHC – 2019

Monday, January 14th 2019

HCC today and the future -

DAY 1 – Friday, August 28

Friday, August 28th 2015

Can we predict HCC in chronic viral hepatitis? (chairman) -

2nd PHC – 2007

Monday, January 22nd 2007

1st session (chairman)

3rd PHC – 2009

Tuesday, January 20th 2009

Luncheons - Room 3 (chairman)

Screening and diagnosis of hepatocellular carcinoma -

4th PHC – 2011

Monday, January 17th 2011

How I manage my patients with hepatocellular carcinoma -

Tuesday, January 18th 2011

Interactive luncheons: regional management issues - Room 2 (chairman)

5th PHC – 2012

Monday, January 30th 2012

Triple therapy today. Phase III results in G1 naïve patients (chairman)

Tuesday, January 31st 2012

Interactive Luncheons - Room 3 (chairman)

6th PHC – 2013

Monday, January 14th 2013

How to optimize current therapy of G1 patients (chairman)

Tuesday, January 15th 2013

Interactive Luncheons - Room 3 (chairman)

7th PHC – 2014

Monday, January 13th 2014

Interactive luncheons - Room 2 (chairman)

Tuesday, January 14th 2014

Impact of HBV therapy on the incidence of hepatocellular carcinoma -

11th PHC – 2018

Monday, January 15th 2018

- Speakers: (chairman) -

Tuesday, January 16th 2018

HCC SESSION  (chairman)

10th PHC – 2017

Monday, January 30th 2017

LUNCH WORKSHOPS - 6-Treatment of HCC in real life (chairman)



Tuesday, January 31st 2017

HCC SESSION (chairman)

8th PHC – 2015

Monday, January 12th 2015

How to improve access to therapy? (chairman) -

Tuesday, January 13th 2015

Management of hepatocellular carcinoma in 2015 -

9th PHC – 2016

Monday, January 11th 2016

How to improve access to therapy? Around the World table - NORTH & WEST (chairman) -

Take home messages (chairman) -

Tuesday, January 12th 2016

Lunch Workshops - Room 242A -

Treatment of hepatocellular carcinoma: beyond international guidelines -